Hims & Hers rises as board member boosts stake amid stock rout

Hims & Hers Health

27/05/2026 12:02

** Shares of telehealth firm Hims & Hers HIMS.N rise 2.2% to $24.38 premarket
** Hims, late on Tuesday, disclosed board member David Wells purchased 48,400 shares on May 26 at an average price of $24.235 per share - SEC filing
** The purchase brought his total stake in HIMS to 224,417 shares
** Wells, a financial veteran who served as Netflix's NFLX.O CFO, has been on HIMS' board since 2020
** Hims stock is down 66% from its 52-week high of $70.42 hit on July 31 last year
** The stock has faced a bruising year with FDA crackdown on its compounded weight-loss drugs, a patent lawsuit from Novo Nordisk NOVOb.CO and a miss in quarterly results weighing
** HIMS had 231.46 million outstanding shares and a market value of $5.52 billion as of the last close - LSEG data
** As of last close, stock down 26.6% YTD

(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))